NXT2B

Founded in 2011 by Swedish entrepreneur Bengt Ågerup, NXT2B was established as a privately owned investment company. The firm’s focus is growth equity: partnering with ambitious entrepreneurs and businesses in healthcare-related fields, rather than investing across every sector. Its stated areas of interest include healthcare, medical devices and specialty pharmaceutical companies.

Based in Uppsala, Sweden, NXT2B describes itself as a venture capital company and is also characterized in company profiles as a private equity firm. Its portfolio includes businesses such as AllgoHolding AB, Hansa Biopharma AB, Lokon Pharma AB, Lumina Adhesives AB and Navinci Diagnostics. NXT2B’s privately owned structure is described in third-party investor listings as enabling it to make investment decisions without requiring external capital.